Company intelligence / Profile preview

Palkion

Salt Lake City, Utah, USA

Ownership: Private
Development stage: Other

Overview

Palkion is a biotechnology company focused on developing oral small molecule therapies for iron-related diseases. The company's research centers on the regulation of ferroportin, the protein responsible for transporting iron out of cells and into the bloodstream. By modulating ferroportin activity, Palkion aimed to address conditions characterized by iron overload, such as hereditary hemochromatosis and certain types of anemia. The company was founded based on research from the University of Utah and was acquired by Disc Medicine in May 2023 to bolster their hematology portfolio.

Therapeutic areas: Hematology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Palkion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Palkion.

Explore the full profile